Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "high-dose"
Home
Blurry Vision and Sudden Limb Weakness Could Signal Multiple Sclerosis, Not Just Stroke
When vision suddenly turns cloudy in one eye and an arm or leg feels unexpectedly weak, many patients immediately fear a stroke.
08/22/2026, 04:13 ET
Yonsei Cancer Center Expands Carbon-Ion Therapy to Head and Neck Cancers, Sarcomas, and Recurrent Rectal Cancers
For patients facing cancers that are anatomically difficult to operate on or resistant to conventional radiation—as well as those dealing with local...
08/22/2026, 04:13 ET
Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study
An animal study has revealed that combining GC Green Cross Wellbeing’s human placental hydrolysate treatment, Laennec...
08/21/2026, 21:10 ET
Cooking Chicken Breast Without the Dryness: How to Maximize Texture and Protein
Chicken breast is a mainstay for weight loss and muscle maintenance. High in protein and low in fat, it serves as an...
08/21/2026, 20:10 ET
Don't Take All Your Supplements at Once: A Morning-to-Night Guide to Optimal Timing
Many people take whatever supplements they missed earlier in the day right before bed or wash them down with morning...
08/17/2026, 10:19 ET
Can You Take Too Many Supplements? Symptoms That Signal You Are Overdoing It
Supplements can be a convenient way to fill nutritional gaps, but consuming more than your body needs can harm your...
08/07/2026, 04:39 ET
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival
Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...
08/02/2026, 06:52 ET
Prevention vs. Treatment: Why Cancer Therapy Demands a Completely Different Diet
What makes diabetes particularly dangerous is the risk of severe, systemic complications.
07/30/2026, 20:45 ET
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.
07/27/2026, 05:31 ET
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data
HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
07/26/2026, 08:54 ET
Previous
2
3
4
5
6
Next